SureGene LLC
Records under this name other than patents SureGene LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,790,396 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,586,308 | Genetic markers of mental illness Lapsed on the fee record Ended Nov 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 19, 2025 | From the USPTO record |
| US 9,738,934 | Genetic markers of mental illness Formerly held Lapsed on the fee record Ended Aug 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2025 | From the USPTO record |
| US 8,460,868 | Genetic markers for schizophrenia and bipolar disorder Lapsed on the fee record Ended Jun 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2025 | From the USPTO record |
| US 7,985,551 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Formerly held Lapsed on the fee record Ended Jul 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 26, 2023 | From the USPTO record |
| US 7,972,793 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Formerly held Lapsed on the fee record Ended Jul 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 5, 2023 | From the USPTO record |
| US 7,951,542 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Formerly held Lapsed on the fee record Ended May 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2023 | From the USPTO record |
| US 7,951,543 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Formerly held Lapsed on the fee record Ended May 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2023 | From the USPTO record |
| US 9,040,241 | Genetic markers of mental illness Lapsed on the fee record Ended May 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 26, 2023 | From the USPTO record |
| US 7,932,042 | Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature Formerly held Lapsed on the fee record Ended Apr 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2023 | From the USPTO record |